Cardiologist Compares Amlodipine and Metoprolol — The Winner Surprises Most Seniors

4 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Two of the most prescribed blood pressure medications in the world.
Millions of seniors take one or the other every morning.
But in 2006, the UK's NICE guidelines formally removed
beta blockers from first-line hypertension treatment
after a landmark trial. Most American seniors
were never told why.

In this video, Dr. Elena Pierce covers:
✔ The ASCOT Trial (Lancet, 19,000+ patients):
amlodipine group had 23% fewer major CV events,
fewer strokes, fewer heart attacks, and lower
new-onset diabetes rates vs. beta blocker group
✔ Why the UK removed beta blockers from first-line
hypertension guidelines — and why millions of US
seniors are still on them
✔ Metoprolol's specific side effect profile in
seniors: exercise intolerance, 22% higher
diabetes risk (JACC meta-analysis), cognitive
slowing, orthostatic fall risk
✔ Amlodipine's actual side effect profile —
what peripheral edema means (and doesn't mean)
✔ The critical distinction: when metoprolol IS
the right medication (heart failure, AFib,
post-MI) vs. when it isn't
✔ 4 specific questions to bring to your next
appointment — word for word

⚠️ NEVER stop metoprolol or any beta blocker
without physician supervision. Abrupt withdrawal
can trigger dangerous rebound cardiovascular events
including arrhythmia and heart attack.
Any transition must be gradual and monitored.

???? Comment "ON METOPROLOL" if you're currently
taking it for blood pressure.
???? Comment "ON AMLODIPINE" to share your experience.
???? Comment "ASKING MY DOCTOR" if you're bringing
this to your next appointment.

???? Subscribe — evidence-based senior health every week.

Dr. Elena Pierce | Senior Health
Categoria
Cardiology
Commenta per primo questo video.

Prossimo